– Many cancer patients in low- and middle-income nations who would benefit from radiation treatment don’t receive it, a new study finds. “In Ghana and the Philippines, for example, about eight in 10 cancer patients who need radiation therapy will not receive needed treatment,” said study co-author Dr. Elena Fidarova, ... Read More »
Here are five things in technology that happened this past week and how they affect your business. Did you miss them? 1 – Yahoo YHOO -3.06% confirms that 500 million accounts were hacked back in 2014. From Forbes: Bob Lord, chief information security officer at Yahoo, has stated that the ... Read More »
U.S. drugmaker Pfizer Inc’s breast cancer drug, Ibrance, should be given marketing approval, an advisory committee at the European Medicines Agency recommended. The Committee for Medicinal Products for Human Use (CHMP) gave a positive opinion for Ibrance to be used in combination with two existing therapies in women who have ... Read More »
U.S. Vice President Joseph Biden on Friday announced new measures to help cancer patients navigate the clinical trials process as part of the administration’s “Cancer Moonshot” initiative to speed new treatments to market. In a statement released ahead of a planned speech at Rice University in Houston, Biden said clinical ... Read More »
Cervical cancer has the possibility of elimination and can be eradicated from many countries in the world in four to five decades, said Dr. R. Sankaranarayanan, Special Advisor on cancer control and head of screening group with the World Health Organisation (WHO), at the Asia-Oceania Research Organisation in Genital Infection ... Read More »
Editor’s note: This is the first in a four-part series on the Community Health Needs Assessment completed by SIH. Next week’s story will be on diabetes and obesity and their roles in heart disease. When Southern Illinois Healthcare released findings from its Community Health Needs Assessment in March, they chose ... Read More »
As a primary care doctor who gets to know and follow patients over many years, I like to think of myself as a trusted health advisor. When it comes to advice about lifestyle issues that affect health, I rarely think in terms that are black or white. There are exceptions ... Read More »
Shares of Bristol-Myers Squibb were hit hard in pre-market trading Friday after news that its blockbuster cancer drug failed a key clinical trial. The drug, called Opdivo, is one of a new set of drugs called immunotherapy. The drug targets the programmed cell death 1 (or PD-1) receptor to essentially ... Read More »
THURSDAY, July 28, 2016 — Men with low-risk prostate cancer report a good quality of life after choosing active surveillance as a treatment for their disease, a new study finds. Active surveillance for prostate cancer means a man chooses not to have surgery, radiation or chemotherapy, but instead follows a ... Read More »
Researchers in England have identified a large group of genes that may be significant for better testing and treatment of prostate cancer. Glycan sugar groups on the surface of prostate cancer cells were found to react to changes in testosterone levels that help the disease grow and spread, and may ... Read More »
FRIDAY, July 29, 2016 — More people are surviving cancer, but many are left with persistent pain after treatment. New guidelines from the American Society of Clinical Oncology (ASCO) recommend that doctors routinely screen for such pain. The guidelines also advise doctors to consider the use of non-traditional treatments for ... Read More »
A patch delivering one, two or three types of colon cancer treatment could make surgery for the disease unnecessary, according to researchers who developed it. Gene therapy, chemotherapy, thermal ablation, or a combination of the three, can be delivered by a hydrogel patch, a method shown to shrink tumors in ... Read More »
